Israeli study shows Pfizer vaccine 94% effective

From the creator

Israel's largest healthcare provider has said a study of more than half a million fully vaccinated Israelis indicated the Pfizer/BioNTech jab gave 94% protection against Covid-19. Clalit Health Services said that in a groundbreaking project its researchers tested 600,000 subjects who had received the recommended two doses of the Pfizer/BioNTech vaccine and the same number of people who had not been innoculated. "There was a 94% reduction in the rate of symptomatic infection and a 92% decrease in the rate of serious illness compared to 600,000 similar (subjects) who were not vaccinated," Clalit said in a Hebrew-language statement. "Vaccine efficacy is maintained in all age groups, including those aged 70+," it added. Israel's mass vaccination campaign has seen 3.8 million people receive a first dose, while 2.4 million have also received a second shot.

Published 2021-02-15 · Watch on YouTube ↗
Availability and playback restrictions are controlled by the original channel.